Mayor P, Gay LM, Lele S, Elvin JA.
BRCA1 reversion mutation acquired after treatment identified by liquid biopsy.
Gynecol Oncol Rep 2017;
21:57-60. [PMID:
28706968 PMCID:
PMC5496455 DOI:
10.1016/j.gore.2017.06.010]
[Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/27/2017] [Revised: 06/14/2017] [Accepted: 06/17/2017] [Indexed: 10/25/2022] Open
Abstract
•Secondary, reversion mutations in BRCA genes can restore protein function.•Reversion mutations can underlie resistance to therapies such as PARP inhibitors.•Reversion mutations arise during the course of treatment.
Collapse